THE IGA NEPHROPATHY FOUNDATION OF AMERICA INC

EIN: 201155709 501(c)(3) Medical Research

WALL, NJ

Total Revenue
$2,588,671
Total Expenses
$2,238,700
Total Assets
$2,684,687
Net Assets
$2,152,631
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2004
Legal Domicile
NJ
Principal Officer
LEONARD ERLANGER
Phone
7327707377
Tax Period
2024-01-01 to 2024-12-31

THE IGA NEPHROPATHY FOUNDATION OF AMERICA INC, founded in 2004, is a community nonprofit in the Medical Research sector that reported $2.6M in total revenue in fiscal year 2024. Revenue decreased 16% compared to the prior year. Expenses of $2.2M left a modest 14% surplus.

Mission

THE IGA NEPHROPATHY FOUNDATION'S MISSION IS TO BE A PATIENT-CENTRIC ORGANIZATION FOCUSED ON FINDING A CURE FOR IGA NEPHROPATHY. USING THE POWER OF THE PATIENT COMMUNITY, WE ARE FOCUSED ON FUNDING RESEARCH, USING PATIENT ADVOCACY TO EMPOWER OUR PATIENTS, AND BUILDING A NETWORK OF SUPPORT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,516,994
Program Service Revenue $1,852
Investment Income $69,825
Other Revenue $0
TOTAL REVENUE $2,588,671

Expense Breakdown

Grants Paid $108,000
Salaries & Benefits $482,088
Fundraising Expenses $74,529
Program Expenses $1,738,332
Other Expenses $1,648,612
TOTAL EXPENSES $2,238,700

Year-over-Year Comparison

2024 2023 Change
Revenue $2,588,671 $3,091,217 -0.2%
Expenses $2,238,700 $1,909,354 +0.2%
Net Income $349,971 $1,181,863 -0.7%
Key Indicators
✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
12
Independent Members
12
Employees
10
Volunteers
100

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
⚠ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
5
$168,546
Total Directors
12
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
LEONARD ERLANGER PRESIDENT 5.00
Officer Director
$0 $0 $0
BRIAN PARLATO VICE PRESIDENT 5.00
Officer Director
$0 $0 $0
MARY KATE SCHNEIDER SECRETARY 5.00
Officer Director
$0 $0 $0
JULIE SCROGGINS TREASURER 5.00
Officer Director
$0 $0 $0
JODY MORSE DIRECTOR 2.00
Director
$0 $0 $0
MICHAEL WARNER DIRECTOR 2.00
Director
$0 $0 $0
EDWARD SCHNEIDER DIRECTOR 2.00
Director
$0 $0 $0
HAROLD COTLER DIRECTOR 2.00
Director
$0 $0 $0
AMI GOPALAN DIRECTOR 2.00
Director
$0 $0 $0
JOHN WOJTAL ESQ DIRECTOR 2.00
Director
$0 $0 $0
MARGARET WARNER DIRECTOR 2.00
Director
$0 $0 $0
SUSAN SMITH DIRECTOR 2.00
Director
$0 $0 $0
BONNIE SCHNEIDER EXECUTIVE DIRECTOR 35.00
Officer
$162,063 $6,483 $168,546
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $2,588,671 $2,238,700 $2,684,687 $349,971
2023 $3,091,217 $1,909,354 $1,853,170 $1,181,863
2022 $1,466,953 $1,193,514 $710,704 $273,439
2022 $1,466,952 $1,261,962 $710,705 $204,990
2021 $632,171 $302,767 $435,197 $329,404
2020 $248,977 $187,128 $103,901 $61,849
Explore More Nonprofits
→Top 100 Nonprofits in New Jersey →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare THE IGA NEPHROPATHY FOUNDATION OF AMERICA INC with other nonprofits in New Jersey and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.